-
1 Comment
Zhuhai Sailong Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 1.9% below its 200 day moving average.
From a valuation standpoint, the stock is 23.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.4.
Zhuhai Sailong Pharmaceutical Co.,Ltd's total revenue sank by 51.1% to $38M since the same quarter in the previous year.
Its net income has dropped by 197.3% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 81.0% to $-8M since the same quarter in the previous year.
Based on the above factors, Zhuhai Sailong Pharmaceutical Co.,Ltd gets an overall score of 2/5.
| ISIN | CNE1000032S5 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | SHE |
| CurrencyCode | CNY |
| Dividend Yield | 0.3% |
|---|---|
| Beta | 0.09 |
| Market Cap | 1B |
| PE Ratio | None |
| Target Price | None |
Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding drugs, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002898.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
